The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Primaquine-Global Market Insights and Sales Trends 2025
Synopsis
Primaquine, mainly used to eradicate vivax malaria and control malaria transmission, is often used with chloroquine or pyrimethamine.
The global Primaquine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Primaquine in various end use industries. The expanding demands from the Hospital, Clinic, Laboratory and Others, are propelling Primaquine market. Injectables Primaquine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules Primaquine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Primaquine market, driven by demand from China, the second largest economy with some signs of stabilising, the Primaquine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Primaquine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Primaquine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Primaquine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Primaquine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Primaquine covered in this report include Cyper Pharma, Santa Cruz Biotechnology, Pfizer and Summit Medical Group, etc.
The global Primaquine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cyper Pharma
Santa Cruz Biotechnology
Pfizer
Summit Medical Group
Global Primaquine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Primaquine market, Segment by Type:
Injectables Primaquine
Capsules Primaquine
Tablets Primaquine
Global Primaquine market, by Application
Hospital
Clinic
Laboratory
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Primaquine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Primaquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Primaquine, mainly used to eradicate vivax malaria and control malaria transmission, is often used with chloroquine or pyrimethamine.
The global Primaquine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Primaquine in various end use industries. The expanding demands from the Hospital, Clinic, Laboratory and Others, are propelling Primaquine market. Injectables Primaquine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules Primaquine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Primaquine market, driven by demand from China, the second largest economy with some signs of stabilising, the Primaquine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Primaquine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Primaquine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Primaquine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Primaquine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Primaquine covered in this report include Cyper Pharma, Santa Cruz Biotechnology, Pfizer and Summit Medical Group, etc.
The global Primaquine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cyper Pharma
Santa Cruz Biotechnology
Pfizer
Summit Medical Group
Global Primaquine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Primaquine market, Segment by Type:
Injectables Primaquine
Capsules Primaquine
Tablets Primaquine
Global Primaquine market, by Application
Hospital
Clinic
Laboratory
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Primaquine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Primaquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Primaquine Market Overview
1.1 Primaquine Product Overview
1.2 Primaquine Market Segment by Type
1.2.1 Injectables Primaquine
1.2.2 Capsules Primaquine
1.2.3 Tablets Primaquine
1.3 Global Primaquine Market Size by Type
1.3.1 Global Primaquine Market Size Overview by Type (2018-2029)
1.3.2 Global Primaquine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Primaquine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Primaquine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Primaquine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Primaquine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Primaquine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Primaquine Sales Breakdown by Type (2018-2023)
2 Global Primaquine Market Competition by Company
2.1 Global Top Players by Primaquine Sales (2018-2023)
2.2 Global Top Players by Primaquine Revenue (2018-2023)
2.3 Global Top Players by Primaquine Price (2018-2023)
2.4 Global Top Manufacturers Primaquine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Primaquine Market Competitive Situation and Trends
2.5.1 Primaquine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Primaquine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Primaquine as of 2022)
2.7 Date of Key Manufacturers Enter into Primaquine Market
2.8 Key Manufacturers Primaquine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Primaquine Status and Outlook by Region
3.1 Global Primaquine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Primaquine Historic Market Size by Region
3.2.1 Global Primaquine Sales in Volume by Region (2018-2023)
3.2.2 Global Primaquine Sales in Value by Region (2018-2023)
3.2.3 Global Primaquine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Primaquine Forecasted Market Size by Region
3.3.1 Global Primaquine Sales in Volume by Region (2024-2029)
3.3.2 Global Primaquine Sales in Value by Region (2024-2029)
3.3.3 Global Primaquine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Primaquine by Application
4.1 Primaquine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Laboratory
4.1.4 Others
4.2 Global Primaquine Market Size by Application
4.2.1 Global Primaquine Market Size Overview by Application (2018-2029)
4.2.2 Global Primaquine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Primaquine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Primaquine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Primaquine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Primaquine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Primaquine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Primaquine Sales Breakdown by Application (2018-2023)
5 North America Primaquine by Country
5.1 North America Primaquine Historic Market Size by Country
5.1.1 North America Primaquine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Primaquine Sales in Volume by Country (2018-2023)
5.1.3 North America Primaquine Sales in Value by Country (2018-2023)
5.2 North America Primaquine Forecasted Market Size by Country
5.2.1 North America Primaquine Sales in Volume by Country (2024-2029)
5.2.2 North America Primaquine Sales in Value by Country (2024-2029)
6 Europe Primaquine by Country
6.1 Europe Primaquine Historic Market Size by Country
6.1.1 Europe Primaquine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Primaquine Sales in Volume by Country (2018-2023)
6.1.3 Europe Primaquine Sales in Value by Country (2018-2023)
6.2 Europe Primaquine Forecasted Market Size by Country
6.2.1 Europe Primaquine Sales in Volume by Country (2024-2029)
6.2.2 Europe Primaquine Sales in Value by Country (2024-2029)
7 Asia-Pacific Primaquine by Region
7.1 Asia-Pacific Primaquine Historic Market Size by Region
7.1.1 Asia-Pacific Primaquine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Primaquine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Primaquine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Primaquine Forecasted Market Size by Region
7.2.1 Asia-Pacific Primaquine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Primaquine Sales in Value by Region (2024-2029)
8 Latin America Primaquine by Country
8.1 Latin America Primaquine Historic Market Size by Country
8.1.1 Latin America Primaquine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Primaquine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Primaquine Sales in Value by Country (2018-2023)
8.2 Latin America Primaquine Forecasted Market Size by Country
8.2.1 Latin America Primaquine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Primaquine Sales in Value by Country (2024-2029)
9 Middle East and Africa Primaquine by Country
9.1 Middle East and Africa Primaquine Historic Market Size by Country
9.1.1 Middle East and Africa Primaquine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Primaquine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Primaquine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Primaquine Forecasted Market Size by Country
9.2.1 Middle East and Africa Primaquine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Primaquine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Cyper Pharma
10.1.1 Cyper Pharma Company Information
10.1.2 Cyper Pharma Introduction and Business Overview
10.1.3 Cyper Pharma Primaquine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Cyper Pharma Primaquine Products Offered
10.1.5 Cyper Pharma Recent Development
10.2 Santa Cruz Biotechnology
10.2.1 Santa Cruz Biotechnology Company Information
10.2.2 Santa Cruz Biotechnology Introduction and Business Overview
10.2.3 Santa Cruz Biotechnology Primaquine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Santa Cruz Biotechnology Primaquine Products Offered
10.2.5 Santa Cruz Biotechnology Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Primaquine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Primaquine Products Offered
10.3.5 Pfizer Recent Development
10.4 Summit Medical Group
10.4.1 Summit Medical Group Company Information
10.4.2 Summit Medical Group Introduction and Business Overview
10.4.3 Summit Medical Group Primaquine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Summit Medical Group Primaquine Products Offered
10.4.5 Summit Medical Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Primaquine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Primaquine Industrial Chain Analysis
11.4 Primaquine Market Dynamics
11.4.1 Primaquine Industry Trends
11.4.2 Primaquine Market Drivers
11.4.3 Primaquine Market Challenges
11.4.4 Primaquine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Primaquine Distributors
12.3 Primaquine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
